Overview
- As of 2024, there are 1,251 bio companies in South Korea; as for bio-related sites (in order of factories > research centers > headquarters), 413 sites are located in Gyeonggi-do and 308 in Seoul, indicating that the majority of them are distributed in the Seoul/Gyeonggi area.
| Gyeonggi-do | 413 | Jeollanam-do | 37 | Busan | 10 |
|---|---|---|---|---|---|
| Seoul | 308 | Jeollabuk-do | 36 | Ulsan | 12 |
| Daejeon | 95 | Daegu | 25 | Gwangju | 9 |
| Chungcheongbuk-do | 92 | Gyeongsangnam-do | 32 | Jeju | 10 |
| Gangwon-do | 50 | Gyeongsangbuk-do | 31 | Sejong | 6 |
| Chungcheongnam-do | 42 | Incheon | 43 | - | - |
- As of 2024, the number of employees working in 1,251 domestic bio companies is 65,818, which represents an increase of 947 compared to that in 2023.
- Bioindustry manpower consists of 19,788 (30.1%) research personnel, 22,151(33.7%), production personnel and 23,879 (36.3%) other personnel, who are involved in sales and management.
- In 2024, the total investment cost of bioindustry companies for one year was KRW 15,799 billion, and the total investment cost in the bioindustry sector was KRW 4,821 billion (34.7% of the total investment cost).
- The R&D cost was KRW 2,702 billion and the facility investment cost was KRW 2,780 billion.
- As of 2024, Bioindustry sales volume was KRW 22,922 billion, of which domestic sales accounted for KRW 9,211 billion (40.2%) and exports for KRW 13,711 billion (59.8%).
- The domestic market size was KRW 14,193 billion, of which imports accounted for KRW 3,692 billion (28.6%), excluding domestic sales of KRW 9,211 billion (71.4%)






